Estrogen rescues preexisting severe pulmonary hypertension in rats

American Journal of Respiratory and Critical Care Medicine

Volumn 184, Issue 6, 2011, Pages 715-723

  Umar, Soban ^a   Iorga, Andrea ^a   Matori, Humann ^a   Nadadur, Rangarajan D ^a   Li, Jingyuan ^a   Maltese, Federica ^a   Van Der Laarse, Arnoud ^b   Eghbali, Mansoureh ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Estrogen; Estrogen receptors; Inflammation; Neoangiogenesis; Pulmonary hypertension

Indexed keywords

1,3,5 TRIS(4 HYDROXYPHENYL) 4 PROPYLPYRAZOLE; DIARYLPROPIONITRILE; ESTRADIOL; ESTRADIOL RECEPTOR; FUMAGILLOL CHLOROACETYLCARBAMATE; MONOCROTALINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD VESSEL; CONTROLLED STUDY; DRUG WITHDRAWAL; ECHOCARDIOGRAPHY; FEMALE; HEART CATHETERIZATION; HEART RIGHT VENTRICLE FAILURE; HEART RIGHT VENTRICLE HYPERTROPHY; IMMUNOHISTOCHEMISTRY; INFLAMMATION; LUNG FIBROSIS; LUNG FUNCTION; LUNG STRUCTURE; MALE; NONHUMAN; PRIORITY JOURNAL; PULMONARY HYPERTENSION; RAT; REAL TIME POLYMERASE CHAIN REACTION; SURVIVAL; WESTERN BLOTTING;

ANIMALS; BLOOD PRESSURE; BLOTTING, WESTERN; ESTRADIOL; ESTROGENS; HEART; HYPERTENSION, PULMONARY; MALE; PULMONARY ARTERY; RATS; RATS, SPRAGUE-DAWLEY; REAL-TIME POLYMERASE CHAIN REACTION; SEVERITY OF ILLNESS INDEX;

EID: 80052917956     PISSN: 1073449X     EISSN: 15354970     Source Type: Journal    
DOI: 10.1164/rccm.201101-0078OC     Document Type: Article

References (56)

1. Umar S, de Visser YP, Steendijk P, Schutte CI, Laghmani EH, Wagenaar GTM, Bax WH, Mantikou E, Pijnappels DA, Atsma DE, et al. Allogenic stem cell therapy improves right ventricular function by improving lung pathology in rats with pulmonary hypertension. Am J Physiol Heart Circ Physiol 2009;297:H1606-H1616.
2. Takemiya K, Kai H, Yasukawa H, Tahara N, Kato S, Imaizumi T. Mesenchymal stem cell-based prostacyclin synthase gene therapy for pulmonary hypertension rats. Basic Res Cardiol 2010;105:409-417.
3. Wang XX, Zhang FR, Shang YP, Zhu JH, Xie XD, Tao QM, Zhu JH, Chen JZ. Transplantation of autologous endothelial progenitor cells may be beneficial in patients with idiopathic pulmonary arterial hypertension: a pilot randomized controlled trial. J Am Coll Cardiol 2007;49:1566-1571.
4. Farhat MY, Chen MF, Bhatti T, Iqbal A, Cathapermal S, Ramwell PW. Protection by oestradiol against the development of cardiovascular changes associated with monocrotaline pulmonary hypertension in rats. Br J Pharmacol 1993;110:719-723. (Pubitemid 23279284)
5. Yen CH, Leu S, Lin YC, Kao YH, Chang LT, Chua S, Fu M, Wu CJ, Sun CK, Yip HK. Sildenafil limits monocrotaline-induced pulmonary hypertension in rats through suppression of pulmonary vascular remodeling. J Cardiovasc Pharmacol 2010;55:574-584.
6. Clozel M, Hess P, Rey M, Iglarz M, Binkert C, Qiu C. Bosentan, sildenafil, and their combination in the monocrotaline model of pulmonary hypertension in rats. Exp Biol Med (Maywood) 2006;231:967-973. (Pubitemid 43845561)
7. Frost AE, Badesch DB, Barst RJ, Benza RL, Elliott CG, Farber HW, Krichman A, Liou TG, Raskob GE, Wason P, et al. The changing picture of pulmonary arterial hypertension (PAH) patients in the United States: how the REVEAL registry differs from historic and non-US contemporary registries. Chest 2011;139:128-137.
8. Rabinovitch M, Gamble WJ, Miettinen OS, Reid L. Age and sex influence on pulmonary hypertension of chronic hypoxia and on recovery. Am J Physiol Heart Circ Physiol 1981;240:H62-H72.
9. Tofovic SP, Zhang X, Jackson EK, Dacic S, Petrusevska G. 2- Methoxyestradiol mediates the protective effects of estradiol in monocrotaline-induced pulmonary hypertension. Vascul Pharmacol 2006;45:358-367. (Pubitemid 44765298)
10. Sweeney LB, Bogaard HJ, Natarajan R, Kraskauskas D, Voelkel NF. Female gender protects against angioproliferative pulmonary hypertension induced by VEGF receptor inhibition and hypoxic exposure. Am J Respir Crit Care Med 2009;179:A1826.
11. Xu DQ, Luo Y, Liu Y, Wang J, Zhang B, Xu M, Wang YX, Dong HY, Dong MQ, Zhao PT, et al. Beta-estradiol attenuates hypoxic pulmonary hypertension by stabilizing the expression of p27kip1 in rats. Respir Res 2010;11:182.
12. Cowan KN, Heilbut A, Humpl T, Lam C, Ito S, Rabinovitch M. Complete reversal of fatal pulmonary hypertension in rats by a serine elastase inhibitor. Nat Med 2000;6:698-702. (Pubitemid 30398796)
13. Umar S, Matori H, Iorga A, Partow-Navid R, Maltese F, Eghbali M. Estrogen rescues severe pulmonary hypertension and increases survival through stimulation of neoangiogenesis and suppression of inflammation [abstract]. Circulation 2010;122:A18969.
14. Umar S, Nadadur RD, Matori H, Partow-Navid R, Iorga A, Maltese F, Eghbali M. Complete reversal of cardiac and pulmonary remodelling associated with severe pulmonary arterial hypertension by estrogen therapy [abstract]. Am J Respir Crit Care Med 2011;183:A2522.
15. National Institute of Health guide for the care and use of laboratory animals. 1996. NIH publication 85-23.
16. Koskenvuo J, Mirsky R, Zhang Y, Angeli F, Jahn S, Alastalo TP, Schiller N, Boyle A, Chatterjee K, De Marco T, et al. A comparison of echocardiography to invasive measurement in the evaluation of pulmonary arterial hypertension in a rat model. Int J Cardiovasc Imaging 2010;26:509-518. (formerly Cardiac Imaging).
17. Yu HP, Hsieh YC, Suzuki T, Shimizu T, Choudhry MA, Schwacha MG, Chaudry IH. Salutary effects of estrogen receptor-beta agonist on lung injury after trauma-hemorrhage. Am J Physiol Lung Cell Mol Physiol 2006;290:L1004-L1009.
18. Lowes BD, Minobe W, Abraham WT, Rizeq MN, Bohlmeyer TJ, Quaife RA, Roden RL, Dutcher DL, Robertson AD, Voelkel NF, et al. Changes in gene expression in the intact human heart. Downregulation of alpha-myosin heavy chain in hypertrophied, failing ventricular myocardium. J Clin Invest 1997;100:2315-2324. (Pubitemid 27500155)
19. Campbell AIM, Zhao Y, Sandhu R, Stewart DJ. Cell-based gene transfer of vascular endothelial growth factor attenuates monocrotalineinduced pulmonary hypertension. Circulation 2001;104:2242-2248. (Pubitemid 33043307)
20. Gomez A, Bialostozky D, Zajarias A, Santos E, Palomar A, Martinez ML, Sandoval J. Right ventricular ischemia in patients with primary pulmonary hypertension. J Am Coll Cardiol 2001;38:1137-1142. (Pubitemid 32912723)
21. Lahm T, Crisostomo PR, Markel TA, Wang M, Weil BR, Novotny NM, Meldrum DR. The effects of estrogen on pulmonary artery vasoreactivity and hypoxic pulmonary vasoconstriction: potential new clinical implications for an old hormone. Crit Care Med 2008;36:2174-2183.
22. Babiker FA, De Windt LJ, van Eickels M, Thijssen V, Bronsaer RJ, Grohe C, van Bilsen M, Doevendans PA. 17beta-estradiol antagonizes cardiomyocyte hypertrophy by autocrine/paracrine stimulation of a guanylyl cyclase A receptor-cyclic guanosine monophosphatedependent protein kinase pathway. Circulation 2004;109:269-276. (Pubitemid 38114150)
23. Ventetuolo CE, Ouyang P, Bluemke DA, Tandri H, Barr RG, Bagiella E, Cappola AR, Bristow MR, Johnson C, Kronmal RA, et al. Sex hormones are associated with right ventricular structure and function: The MESA-right ventricle study. Am J Respir Crit Care Med 2011; 183:659-667.
24. Dorfmuller P, Perros F, Balabanian K, Humbert M. Inflammation in pulmonary arterial hypertension. Eur Respir J 2003;22:358-363. (Pubitemid 36987011)
25. Speyer CL, Rancilio NJ, McClintock SD, Crawford JD, Gao H, Sarma JV, Ward PA. Regulatory effects of estrogen on acute lung inflammation in mice. Am J Physiol Cell Physiol 2005;288:C881-C890. (Pubitemid 40395066)
26. Brass DM, McGee SP, Dunkel MK, Reilly SM, Tobolewski JM, Sabo- Attwood T, Fattman CL. Gender influences the response to experimental silica-induced lung fibrosis in mice. Am J Physiol Lung Cell Mol Physiol 2010;299:L664-L671.
27. Fliegner D, Schubert C, Penkalla A, Witt H, Kararigas G, Dworatzek E, Staub E, Martus P, Ruiz Noppinger P, Kintscher U, et al. Female sex and estrogen receptor-beta attenuate cardiac remodeling and apoptosis in pressure overload. Am J Physiol Regul Integr Comp Physiol 2010;298:R1597-R1606.
28. Pedram A, Razandi M, O'Mahony F, Lubahn D, Levin ER. Estrogen receptor-beta prevents cardiac fibrosis. Mol Endocrinol 2010;24:2152-2165.
29. Bogaard HJ, Natarajan R, Henderson SC, Long CS, Kraskauskas D, Smithson L, Ockaili R, McCord JM, Voelkel NF. Chronic pulmonary artery pressure elevation is insufficient to explain right heart failure. Circulation 2009;120:1951-1960.
30. Shiojima I, Sato K, Izumiya Y, Schiekofer S, Ito M, Liao R, Colucci WS, Walsh K. Disruption of coordinated cardiac hypertrophy and angiogenesis contributes to the transition to heart failure. J Clin Invest 2005;115:2108-2118. (Pubitemid 41134152)
31. Rodger FE, Young FM, Fraser HM, Illingworth PJ. Endothelial cell proliferation follows the mid-cycle luteinizing hormone surge, but not human chorionic gonadotrophin rescue, in the human corpus luteum. Hum Reprod 1997;12:1723-1729. (Pubitemid 27406087)
32. Ardelt AA, McCullough LD, Korach KS, Wang MM, Munzenmaier DH, Hurn PD. Estradiol regulates angiopoietin-1 mRNA expression through estrogen receptor-{alpha} in a rodent experimental stroke model. Stroke 2005;36:337-341. (Pubitemid 40170819)
33. Chen Y, Jin X, Zeng Z, Liu W,Wang B, Wang H. Estrogen-replacement therapy promotes angiogenesis after acute myocardial infarction by enhancing SDF-1 and estrogen receptor expression. Microvasc Res 2009;77:71-77.
34. Grohe C, Kahlert S, Lobbert K, Vetter H. Expression of oestrogen receptor alpha and beta in rat heart: role of local oestrogen synthesis. J Endocrinol 1998;156:R1-R7. (Pubitemid 28105832)
35. Babiker FA, Lips D, Meyer R, Delvaux E, Zandberg P, Janssen B, van Eys G, Grohe C, Doevendans PA. Estrogen receptor beta protects the murine heart against left ventricular hypertrophy. Arterioscler Thromb Vasc Biol 2006;26:1524-1530. (Pubitemid 44288978)
36. Wang M, Crisostomo PR, Markel T, Wang Y, Lillemoe KD, Meldrum DR. Estrogen receptor beta mediates acute myocardial protection following ischemia. Surgery 2008;144:233-238.
37. Zhu Y, Bian Z, Lu P, Karas RH, Bao L, Cox D, Hodgin J, Shaul PW, Thoren P, Smithies O, et al. Abnormal vascular function and hypertension in mice deficient in estrogen receptor beta. Science 2002;295: 505-508. (Pubitemid 34101642)
38. Pelzer T, Loza PAA, Hu K, Bayer B, Dienesch C, Calvillo L, Couse JF, Korach KS, Neyses L, Ertl G. Increased mortality and aggravation of heart failure in estrogen receptor-{beta} knockout mice after myocardial infarction. Circulation 2005;111:1492-1498. (Pubitemid 40470643)
39. Lahm T, Albrecht M, Fisher A, Justice M, Van Demark M, Patel N, Presson RG Jr, Petrache I. 17-beta estradiol (E2) attenuates hypoxiainduced pulmonary hypertension through an estrogen receptordependent, but E2 metabolite- independent mechanism. Am J Respir Crit Care Med 2011;183:A2521.
40. Zhao C, Dahlman-Wright K, Gustafsson JA. Estrogen signaling via estrogen receptor {beta}. J Biol Chem 2010;285:39575-39579.
41. De MT. Pulmonary arterial hypertension and women. Cardiol Rev 2006; 14:312-318.
42. Resta TC, Kanagy NL, Walker BR. Estradiol-induced attenuation of pulmonary hypertension is not associated with altered eNOS expression. Am J Physiol Lung Cell Mol Physiol 2001;280:L88-L97.
43. Homma N, Morio Y, Takahashi H, Yamamoto A, Suzuki T, Sato K, Muramatsu M, Fukuchi Y. Genistein, a phytoestrogen, attenuates monocrotaline-induced pulmonary hypertension. Respiration 2006;73: 105-112.
44. Nishida M, Hasegawa Y, Tanida I, Nakagawa E, Inaji H, Ohkita M, Matsumura Y. Preventive effects of raloxifene, a selective estrogen receptor modulator, on monocrotaline-induced pulmonary hypertension in intact and ovariectomized female rats. Eur J Pharmacol 2009;614: 70-76.
45. Morse JH, Horn EM, Barst RJ. Hormone replacement therapy: a possible risk factor in carriers of familial primary pulmonary hypertension. Chest 1999;116:847. (Pubitemid 29428518)
46. Scorza R, Caronni M, Bazzi S, Nador F, Beretta L, Antonioli R, Origgi L, Ponti A, Marchini M, Vanoli M. Post-menopause is the main risk factor for developing isolated pulmonary hypertension in systemic sclerosis. Ann NY Acad Sci 2002;966:238-246. (Pubitemid 34729180)
47. Beretta L, Caronni M, Origgi L, Ponti A, Santaniello A, Scorza R. Hormone replacement therapy may prevent the development of isolated pulmonary hypertension in patients with systemic sclerosis and limited cutaneous involvement. Scand J Rheumatol 2006;35:468-471. (Pubitemid 47215719)
48. Taraseviciute A, Voelkel NF. Severe pulmonary hypertension in postmenopausal obese women. Eur J Med Res 2006;11:198-202.
49. Tofovic PS, Zhang X, Petrusevska G. Progesterone inhibits vascular remodeling and attenuates monocrotaline-induced pulmonary hypertension in estrogen-deficient rats. Prilozi 2009;30:25-44.
50. Jones RD, English KM, Pugh PJ, Morice AH, Jones TH, Channer KS. Pulmonary vasodilatory action of testosterone: evidence of a calcium antagonistic action. J Cardiovasc Pharmacol 2002;39:814-823. (Pubitemid 34538811)
51. English KM, Jones RD, Jones TH, Morice AH, Channer KS. Gender differences in the vasomotor effects of different steroid hormones in rat pulmonary and coronary arteries. Horm Metab Res 2001;33:645-652. (Pubitemid 33151462)
52. Hansmann G, Wagner RA, Schellong S, Perez VA, Urashima T, Wang L, Sheikh AY, Suen RS, Stewart DJ, Rabinovitch M. Pulmonary arterial hypertension is linked to insulin resistance and reversed by peroxisome proliferator-activated receptor-gamma activation. Circulation 2007;115:1275-1284. (Pubitemid 46594772)
53. Pugh ME, Hemnes AR. Development of pulmonary arterial hypertension in women: interplay of sex hormones and pulmonary vascular disease. Womens Health (Lond Engl) 2010;6:285-296.
54. Homma N, Nagaoka T, Karoor V, Imamura M, Taraseviciene-Stewart L, Walker LA, Fagan KA, McMurtry IF, Oka M. Involvement of RhoA/ Rho kinase signaling in protection against monocrotaline-induced pulmonary hypertension in pneumonectomized rats by dehydroepiandrosterone. Am J Physiol Lung Cell Mol Physiol 2008;295:L71-L78.
55. Paruthiyil S, Parmar H, Kerekatte V, Cunha GR, Firestone GL, Leitman DC. Estrogen receptor beta inhibits human breast cancer cell proliferation and tumor formation by causing a G2 cell cycle arrest. Cancer Res 2004;64:423-428. (Pubitemid 38114127)
56. Warner M, Gustafsson JK. The role of estrogen receptor beta (ERbeta) in malignant diseases-a new potential target for antiproliferative drugs in prevention and treatment of cancer. Biochem Biophys Res Commun 2010;396:63-66.